Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and androstenedione

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with androstenedione in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Studies
(androstenedione)
Trials
(androstenedione)
Recent Studies (post-2010) (androstenedione)
319321247,175377960

Protein Interaction Comparison

ProteinTaxonomy2,3-bis(3'-hydroxybenzyl)butyrolactone (IC50)androstenedione (IC50)
CholinesteraseHomo sapiens (human)1.55
AromataseHomo sapiens (human)0.3
Androgen receptorRattus norvegicus (Norway rat)0.6761
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.6826

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adlercreutz, H; Arosemena, PJ; Bannwart, C; Brunow, G; Hase, T; Kellis, JT; Mäkelä, T; Vickery, LE; Wähälä, K1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and androstenedione

ArticleYear
Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:2

    Topics: 4-Butyrolactone; Androstenedione; Animals; Antineoplastic Agents, Phytogenic; Aromatase; Aromatase Inhibitors; Estrogens; Humans; Lignans; Lignin; Spectrum Analysis; Substrate Specificity; Tumor Cells, Cultured

1993